A MET targeting biparatopic antibody-drug conjugates (ADC), REGN5093-M114, has an antitumor efficacy in NSCLC harboring MET gene alterations.Seung Yeon Oh,Sun Min Lim,You Won Lee,Eun Ji Lee,Jae Hwan Kim,Seong Gu Heo,Mi Ra Yu,Min Hee Hong,Hye Ryun Kim,John DaSilva,Christopher Daly,Mi Ran Yun,Byoung Chul ChoCANCER RESEARCH(2022)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要